These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2400225)

  • 1. Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom.
    Simmonds EJ; Conway SP; Ghoneim AT; Ross H; Littlewood JM
    Arch Dis Child; 1990 Aug; 65(8):874-7. PubMed ID: 2400225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis.
    Pegues DA; Schidlow DV; Tablan OC; Carson LA; Clark NC; Jarvis WR
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):805-12. PubMed ID: 7519103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulised anti-pseudomonal antibiotics for cystic fibrosis.
    Ryan G; Mukhopadhyay S; Singh M
    Cochrane Database Syst Rev; 2000; (2):CD001021. PubMed ID: 10796732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis.
    Burdge DR; Nakielna EM; Noble MA
    Infect Control Hosp Epidemiol; 1993 Mar; 14(3):127-30. PubMed ID: 7683031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis.
    Taylor RF; Gaya H; Hodson ME
    Respir Med; 1993 Apr; 87(3):187-92. PubMed ID: 7684530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.
    Tablan OC; Martone WJ; Jarvis WR
    Eur J Epidemiol; 1987 Dec; 3(4):336-42. PubMed ID: 3319668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis.
    Gladman G; Connor PJ; Williams RF; David TJ
    Arch Dis Child; 1992 Feb; 67(2):192-5. PubMed ID: 1371914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.
    Tablan OC; Chorba TL; Schidlow DV; White JW; Hardy KA; Gilligan PH; Morgan WM; Carson LA; Martone WJ; Jason JM
    J Pediatr; 1985 Sep; 107(3):382-7. PubMed ID: 4032134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas cepacia in cystic fibrosis patients.
    Prince A
    Am Rev Respir Dis; 1986 Oct; 134(4):644-5. PubMed ID: 3094414
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology.
    Goldmann DA; Klinger JD
    J Pediatr; 1986 May; 108(5 Pt 2):806-12. PubMed ID: 3517271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes.
    Tablan OC; Martone WJ; Doershuk CF; Stern RC; Thomassen MJ; Klinger JD; White JW; Carson LA; Jarvis WR
    Chest; 1987 Apr; 91(4):527-32. PubMed ID: 3829745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.
    Smith DL; Gumery LB; Smith EG; Stableforth DE; Kaufmann ME; Pitt TL
    J Clin Microbiol; 1993 Nov; 31(11):3017-22. PubMed ID: 7505294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulised antibiotics for adults with cystic fibrosis.
    Webb AK; Dodd ME
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S69-71. PubMed ID: 9155856
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment.
    Pitchford KC; Corey M; Highsmith AK; Perlman R; Bannatyne R; Gold R; Levison H; Ford-Jones EL
    J Pediatr; 1987 Aug; 111(2):212-6. PubMed ID: 3612391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis.
    Thomassen MJ; Demko CA; Doershuk CF; Stern RC; Klinger JD
    Am Rev Respir Dis; 1986 Oct; 134(4):669-71. PubMed ID: 3767122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas cepacia in cystic fibrosis.
    Stableforth DE; Smith DL
    Thorax; 1994 Jul; 49(7):629-30. PubMed ID: 7520606
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009.
    Lillquist YP; Cho E; Davidson AG
    J Cyst Fibros; 2011 May; 10(3):175-80. PubMed ID: 21310671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates.
    Tramper-Stranders GA; van der Ent CK; Molin S; Yang L; Hansen SK; Rau MH; Ciofu O; Johansen HK; Wolfs TF
    Clin Microbiol Infect; 2012 Jun; 18(6):567-74. PubMed ID: 21883670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.